Evaluation of Multiple Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis-I
All newborn screening (NBS) for mucopolysaccharidosis-I (MPS-I) is carried out by the measurement of α-iduronidase (IDUA) enzymatic activity in dried blood spots (DBS). The majority of low enzyme results are due to pseudodeficiencies, and studies from the Mayo Clinic have shown that the false positi...
Saved in:
Main Authors: | Zackary M. Herbst (Author), Leslie Urdaneta (Author), Terri Klein (Author), Maria Fuller (Author), Michael H. Gelb (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2020-08-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Evaluation of Two Methods for Quantification of Glycosaminoglycan Biomarkers in Newborn Dried Blood Spots from Patients with Severe and Attenuated Mucopolysaccharidosis Type II
by: Zackary M. Herbst, et al.
Published: (2022) -
Direct Derivatization in Dried Blood Spots for Oxidized and Reduced Glutathione Quantification in Newborns
by: Isabel Ten-Doménech, et al.
Published: (2022) -
Newborn Screening for Lysosomal Storage Disorders: Methodologies for Measurement of Enzymatic Activities in Dried Blood Spots
by: Michael H. Gelb, et al.
Published: (2018) -
Newborn Screening for Mucopolysaccharidosis I: Moving Forward Learning from Experience
by: Lorne A. Clarke, et al.
Published: (2020) -
Creatine and creatinine quantification in olympic athletes: dried blood spot analysis pilot study
by: Flavio I. Bachini, et al.
Published: (2021)